Bayer | BAYN - Operating Expenses

Stock Price
38.50
Daily Change
-1.54 -3.85%
Monthly
0.59%
Yearly
67.54%
Q2 Forecast
37.49

Bayer reported EUR10.33B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Air Liquide EUR 10.37B 6.15B Dec/2025
Akzo Nobel EUR 2.13B 23M Mar/2026
Alcon AG USD 2.41B 123M Dec/2025
Amarin USD 51.48M 113K Dec/2025
Arkema EUR 2.08B 0 Dec/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 14.21B 372M Dec/2025
Bayer EUR 10.33B 126M Dec/2025
Beiersdorf EUR 4.16B 212M Dec/2025
Corteva USD 3.1B 217M Dec/2025
Covestro EUR 3.24B 5.46B Dec/2025
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 5.25B 337M Dec/2025
Fresenius Medical Care EUR 4.41B 27.91M Dec/2025
Genmab DKK 798M 235M Dec/2025
Givaudan CHF 3B 107M Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GRIFOLS EUR 1.71B 193M Dec/2025
Henkel EUR 8.67B 122M Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Johnson Matthey GBP 5.21B 600M Dec/2025
Linde USD 6.52B 309M Dec/2025
Lonza CHF 2.9B 184M Jun/2025
Merck EUR 4.78B 669M Dec/2025
Novartis USD 9.8B 61M Dec/2025
Nutrien USD 4.64B 579M Dec/2025
Philips EUR 4.38B 405M Dec/2025
PPG Industries USD 3.46B 4.34B Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Sanofi EUR 9.31B 1.2B Mar/2026
SAP EUR -4.22B 11.13B Mar/2026
Solvay EUR 1.03B 24M Dec/2025
UCB EUR 2.96B 196M Dec/2025
Umicore EUR 8.39B 4.03B Jun/2025
Vinci EUR 34.12B 2.72B Dec/2025